5-13717497-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001369.3(DNAH5):c.12523G>A(p.Val4175Met) variant causes a missense change. The variant allele was found at a frequency of 0.000584 in 1,614,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001369.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH5 | ENST00000265104.5 | c.12523G>A | p.Val4175Met | missense_variant | 73/79 | 1 | NM_001369.3 | ENSP00000265104.4 | ||
DNAH5 | ENST00000681290.1 | c.12478G>A | p.Val4160Met | missense_variant | 73/79 | ENSP00000505288.1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000304 AC: 76AN: 250376Hom.: 0 AF XY: 0.000288 AC XY: 39AN XY: 135418
GnomAD4 exome AF: 0.000609 AC: 890AN: 1461800Hom.: 0 Cov.: 33 AF XY: 0.000595 AC XY: 433AN XY: 727204
GnomAD4 genome AF: 0.000348 AC: 53AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74498
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia 3 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | May 23, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Oct 18, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Primary ciliary dyskinesia Uncertain:2Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2014 | The p.V4175M variant (also known as c.12523G>A), located in coding exon 73 of the DNAH5 gene, results from a G to A substitution at nucleotide position 12523. The valine at codon 4175 is replaced by methionine, an amino acid with highly similar properties. This variant was previously reported in the SNPDatabase as rs148123430. Based on data from the 1000 Genomes Project, the A allele has an overall frequency of approximately 0.05% (1/2098) total alleles studied. The highest observed frequency was 0.59% (1/170) British alleles. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.06% (8/13006) total alleles studied, having been observed in 0.05% (2/4406) African American alleles and 0.07% (6/8600) European American alleles. This amino acid position is highly conserved on sequence alignment. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | May 01, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at